EventsThe 1st International Electronic Conference on Medicinal Chemistry and Pharmaceutics
Published
This submission belongs to the session S11. Formulation, Drug Delivery and Controlled Release of the event The 1st International Electronic Conference on Medicinal Chemistry and Pharmaceutics
Published date
29 Oct, 2025
Academic Editor
author-avatarGareth R. Williams
Citation
Bojana V. Pantovic, Tina P. Andrejević, Darko P. Ašanin, Nevena Lj. Stevanović, Biljana Đ. Glišić, DNA/BSA binding study of iminodiacetate-based gallium(III) complexes, in Proceedings of The 1st International Electronic Conference on Medicinal Chemistry and Pharmaceutics, 1 November–30 November 2025, MDPI: Basel, Switzerland
Share
Email
Facebook
Twitter
LinkedIn

DNA/BSA binding study of iminodiacetate-based gallium(III) complexes

image
image
image
1. Faculty of Science, University of Kragujevac, Radoja Domanovića 12, 34000 Kragujevac, Serbia, Serbia
2. Institute for Information Technologies Kragujevac, University of Kragujevac, Jovana Cvijića bb, 34000 Kragujevac, Serbia, Serbia
Abstract

Gallium(III) complexes have emerged as promising candidates in bioinorganic chemistry due to their structural versatility, stability, and ability to mimic iron in biological systems, which allows them to interact selectively with key biomolecules. Motivated by these properties, we synthesized two novel gallium(III) complexes, Na[Ga(ida)2]·2H2O (1) and K[Ga(ida)2]·3H2O (2), employing iminodiacetate (ida2–) as the ligand. The synthesis of these complexes was carried out in aqueous solution by reacting GaCl3 with iminodiacetic acid (H2ida) at 80 °C for 4 h in the presence of NaOH or KOH, respectively. Their structures were determined using IR and NMR (1H and 13C) spectroscopy and further confirmed through single-crystal X-ray diffraction analysis. Building on this structural work, we investigated their interactions with bovine serum albumin (BSA) and calf thymus DNA (ct-DNA) using fluorescence emission spectroscopy to assess their binding affinity towards these biologically important molecules. Since serum albumin consists of three main domains (I–III), each subdivided into two subdomains (A and B), fluorescence competition experiments with site-specific markers were also performed to identify the preferred binding sites of the complexes. Eosin Y served as a marker for site I (subdomain IIA), ibuprofen for site II (subdomain IIIA), and digitoxin for site III (subdomain IB).

Keywords
BSA/DNA interactions
Iminodiacetate
Gallium(III) complexes
Site markers.
Poster
Poster ECMC-P_Bojana Pantović.pdf
DNA/BSA binding study of mononuclear gold(III) complex with azaconazole
Integrated Computational Assessment of Novel NDM-1 Inhibitors through Molecular Docking, Molecular Dynamics, and MM/GBSA Analysis